0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Inhaled Nitric Oxide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-35M8798
Home | Market Reports | Business & Industrial| Energy & Utilities| Oil & Gas
Global Inhaled Nitric Oxide Market Outlook 2022
BUY CHAPTERS

Inhaled Nitric Oxide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-35M8798
Report
August 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inhaled Nitric Oxide- Market Size

The global market for Inhaled Nitric Oxide was estimated to be worth US$ 1270 million in 2024 and is forecast to a readjusted size of US$ 2202 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.

Inhaled Nitric Oxide- Market

Inhaled Nitric Oxide- Market

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.
North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.
In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhaled Nitric Oxide by region & country, by Type, and by Application.
The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.
Market Segmentation

Scope of Inhaled Nitric Oxide- Market Report

Report Metric Details
Report Name Inhaled Nitric Oxide- Market
Forecasted market size in 2031 US$ 2202 million
CAGR 8.3%
Forecasted years 2025 - 2031
Segment by Type
  • 800 ppm
  • 100 ppm
  • Others
Segment by Application
  • Near-term and Pre-term Infants PPHN
  • Children and Adult ARDS
  • Other Diseases
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mallinckrodt, Praxair (Linde plc), Air Liquide, BOC Healthcare (Linde Group)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Inhaled Nitric Oxide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Inhaled Nitric Oxide in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Inhaled Nitric Oxide- Market size in 2031?

Ans: The Inhaled Nitric Oxide- Market size in 2031 will be US$ 2202 million.

What is the Mallinckrodt share in Inhaled Nitric Oxide- Market?

Ans: Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

What is the Inhaled Nitric Oxide- Market share by type?

Ans: In terms of product, 800 ppm is the largest segment, with a share over 50%.

Who are the main players in the Inhaled Nitric Oxide- Market report?

Ans: The main players in the Inhaled Nitric Oxide- Market are Mallinckrodt, Praxair (Linde plc), Air Liquide, BOC Healthcare (Linde Group)

What are the Application segmentation covered in the Inhaled Nitric Oxide- Market report?

Ans: The Applications covered in the Inhaled Nitric Oxide- Market report are Near-term and Pre-term Infants PPHN, Children and Adult ARDS, Other Diseases

What are the Type segmentation covered in the Inhaled Nitric Oxide- Market report?

Ans: The Types covered in the Inhaled Nitric Oxide- Market report are 800 ppm, 100 ppm, Others

1 Market Overview
1.1 Inhaled Nitric Oxide Product Introduction
1.2 Global Inhaled Nitric Oxide Market Size Forecast
1.2.1 Global Inhaled Nitric Oxide Sales Value (2020-2031)
1.2.2 Global Inhaled Nitric Oxide Sales Volume (2020-2031)
1.2.3 Global Inhaled Nitric Oxide Sales Price (2020-2031)
1.3 Inhaled Nitric Oxide Market Trends & Drivers
1.3.1 Inhaled Nitric Oxide Industry Trends
1.3.2 Inhaled Nitric Oxide Market Drivers & Opportunity
1.3.3 Inhaled Nitric Oxide Market Challenges
1.3.4 Inhaled Nitric Oxide Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Inhaled Nitric Oxide Players Revenue Ranking (2024)
2.2 Global Inhaled Nitric Oxide Revenue by Company (2020-2025)
2.3 Global Inhaled Nitric Oxide Players Sales Volume Ranking (2024)
2.4 Global Inhaled Nitric Oxide Sales Volume by Company Players (2020-2025)
2.5 Global Inhaled Nitric Oxide Average Price by Company (2020-2025)
2.6 Key Manufacturers Inhaled Nitric Oxide Manufacturing Base and Headquarters
2.7 Key Manufacturers Inhaled Nitric Oxide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Inhaled Nitric Oxide
2.9 Inhaled Nitric Oxide Market Competitive Analysis
2.9.1 Inhaled Nitric Oxide Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Inhaled Nitric Oxide Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 800 ppm
3.1.2 100 ppm
3.1.3 Others
3.2 Global Inhaled Nitric Oxide Sales Value by Type
3.2.1 Global Inhaled Nitric Oxide Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Inhaled Nitric Oxide Sales Value, by Type (2020-2031)
3.2.3 Global Inhaled Nitric Oxide Sales Value, by Type (%) (2020-2031)
3.3 Global Inhaled Nitric Oxide Sales Volume by Type
3.3.1 Global Inhaled Nitric Oxide Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Inhaled Nitric Oxide Sales Volume, by Type (2020-2031)
3.3.3 Global Inhaled Nitric Oxide Sales Volume, by Type (%) (2020-2031)
3.4 Global Inhaled Nitric Oxide Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Near-term and Pre-term Infants PPHN
4.1.2 Children and Adult ARDS
4.1.3 Other Diseases
4.2 Global Inhaled Nitric Oxide Sales Value by Application
4.2.1 Global Inhaled Nitric Oxide Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Inhaled Nitric Oxide Sales Value, by Application (2020-2031)
4.2.3 Global Inhaled Nitric Oxide Sales Value, by Application (%) (2020-2031)
4.3 Global Inhaled Nitric Oxide Sales Volume by Application
4.3.1 Global Inhaled Nitric Oxide Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Inhaled Nitric Oxide Sales Volume, by Application (2020-2031)
4.3.3 Global Inhaled Nitric Oxide Sales Volume, by Application (%) (2020-2031)
4.4 Global Inhaled Nitric Oxide Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Inhaled Nitric Oxide Sales Value by Region
5.1.1 Global Inhaled Nitric Oxide Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Inhaled Nitric Oxide Sales Value by Region (2020-2025)
5.1.3 Global Inhaled Nitric Oxide Sales Value by Region (2026-2031)
5.1.4 Global Inhaled Nitric Oxide Sales Value by Region (%), (2020-2031)
5.2 Global Inhaled Nitric Oxide Sales Volume by Region
5.2.1 Global Inhaled Nitric Oxide Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Inhaled Nitric Oxide Sales Volume by Region (2020-2025)
5.2.3 Global Inhaled Nitric Oxide Sales Volume by Region (2026-2031)
5.2.4 Global Inhaled Nitric Oxide Sales Volume by Region (%), (2020-2031)
5.3 Global Inhaled Nitric Oxide Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Inhaled Nitric Oxide Sales Value, 2020-2031
5.4.2 North America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Inhaled Nitric Oxide Sales Value, 2020-2031
5.5.2 Europe Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Inhaled Nitric Oxide Sales Value, 2020-2031
5.6.2 Asia Pacific Inhaled Nitric Oxide Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Inhaled Nitric Oxide Sales Value, 2020-2031
5.7.2 South America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Inhaled Nitric Oxide Sales Value, 2020-2031
5.8.2 Middle East & Africa Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Inhaled Nitric Oxide Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Inhaled Nitric Oxide Sales Value
6.2.1 Key Countries/Regions Inhaled Nitric Oxide Sales Value, 2020-2031
6.2.2 Key Countries/Regions Inhaled Nitric Oxide Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Inhaled Nitric Oxide Sales Value, 2020-2031
6.3.2 United States Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Inhaled Nitric Oxide Sales Value, 2020-2031
6.4.2 Europe Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Inhaled Nitric Oxide Sales Value, 2020-2031
6.5.2 China Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
6.5.3 China Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Inhaled Nitric Oxide Sales Value, 2020-2031
6.6.2 Japan Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Inhaled Nitric Oxide Sales Value, 2020-2031
6.7.2 South Korea Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Inhaled Nitric Oxide Sales Value, 2020-2031
6.8.2 Southeast Asia Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Inhaled Nitric Oxide Sales Value, 2020-2031
6.9.2 India Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
6.9.3 India Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Mallinckrodt
7.1.1 Mallinckrodt Company Information
7.1.2 Mallinckrodt Introduction and Business Overview
7.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Mallinckrodt Inhaled Nitric Oxide Product Offerings
7.1.5 Mallinckrodt Recent Development
7.2 Praxair (Linde plc)
7.2.1 Praxair (Linde plc) Company Information
7.2.2 Praxair (Linde plc) Introduction and Business Overview
7.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Product Offerings
7.2.5 Praxair (Linde plc) Recent Development
7.3 Air Liquide
7.3.1 Air Liquide Company Information
7.3.2 Air Liquide Introduction and Business Overview
7.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Air Liquide Inhaled Nitric Oxide Product Offerings
7.3.5 Air Liquide Recent Development
7.4 BOC Healthcare (Linde Group)
7.4.1 BOC Healthcare (Linde Group) Company Information
7.4.2 BOC Healthcare (Linde Group) Introduction and Business Overview
7.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Offerings
7.4.5 BOC Healthcare (Linde Group) Recent Development
8 Industry Chain Analysis
8.1 Inhaled Nitric Oxide Industrial Chain
8.2 Inhaled Nitric Oxide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Inhaled Nitric Oxide Sales Model
8.5.2 Sales Channel
8.5.3 Inhaled Nitric Oxide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Inhaled Nitric Oxide Market Trends
 Table 2. Inhaled Nitric Oxide Market Drivers & Opportunity
 Table 3. Inhaled Nitric Oxide Market Challenges
 Table 4. Inhaled Nitric Oxide Market Restraints
 Table 5. Global Inhaled Nitric Oxide Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
 Table 7. Global Inhaled Nitric Oxide Sales Volume by Company (2020-2025) & (M L)
 Table 8. Global Inhaled Nitric Oxide Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Inhaled Nitric Oxide Price by Company (2020-2025) & (US$/L)
 Table 10. Key Manufacturers Inhaled Nitric Oxide Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Inhaled Nitric Oxide Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Inhaled Nitric Oxide
 Table 13. Global Inhaled Nitric Oxide Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhaled Nitric Oxide Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Inhaled Nitric Oxide Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Inhaled Nitric Oxide Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Inhaled Nitric Oxide Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Inhaled Nitric Oxide Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Inhaled Nitric Oxide Sales Volume by Type: 2020 VS 2024 VS 2031 (M L)
 Table 22. Global Inhaled Nitric Oxide Sales Volume by Type (2020-2025) & (M L)
 Table 23. Global Inhaled Nitric Oxide Sales Volume by Type (2026-2031) & (M L)
 Table 24. Global Inhaled Nitric Oxide Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Inhaled Nitric Oxide Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Inhaled Nitric Oxide Price by Type (2020-2025) & (US$/L)
 Table 27. Global Inhaled Nitric Oxide Price by Type (2026-2031) & (US$/L)
 Table 28. Global Inhaled Nitric Oxide Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Inhaled Nitric Oxide Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Inhaled Nitric Oxide Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Inhaled Nitric Oxide Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Inhaled Nitric Oxide Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Inhaled Nitric Oxide Sales Volume by Application: 2020 VS 2024 VS 2031 (M L)
 Table 34. Global Inhaled Nitric Oxide Sales Volume by Application (2020-2025) & (M L)
 Table 35. Global Inhaled Nitric Oxide Sales Volume by Application (2026-2031) & (M L)
 Table 36. Global Inhaled Nitric Oxide Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Inhaled Nitric Oxide Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Inhaled Nitric Oxide Price by Application (2020-2025) & (US$/L)
 Table 39. Global Inhaled Nitric Oxide Price by Application (2026-2031) & (US$/L)
 Table 40. Global Inhaled Nitric Oxide Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Inhaled Nitric Oxide Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Inhaled Nitric Oxide Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Inhaled Nitric Oxide Sales Value by Region (2020-2025) & (%)
 Table 44. Global Inhaled Nitric Oxide Sales Value by Region (2026-2031) & (%)
 Table 45. Global Inhaled Nitric Oxide Sales Volume by Region (M L): 2020 VS 2024 VS 2031
 Table 46. Global Inhaled Nitric Oxide Sales Volume by Region (2020-2025) & (M L)
 Table 47. Global Inhaled Nitric Oxide Sales Volume by Region (2026-2031) & (M L)
 Table 48. Global Inhaled Nitric Oxide Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Inhaled Nitric Oxide Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Inhaled Nitric Oxide Average Price by Region (2020-2025) & (US$/L)
 Table 51. Global Inhaled Nitric Oxide Average Price by Region (2026-2031) & (US$/L)
 Table 52. Key Countries/Regions Inhaled Nitric Oxide Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Inhaled Nitric Oxide Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Inhaled Nitric Oxide Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Inhaled Nitric Oxide Sales Volume, (2020-2025) & (M L)
 Table 56. Key Countries/Regions Inhaled Nitric Oxide Sales Volume, (2026-2031) & (M L)
 Table 57. Mallinckrodt Company Information
 Table 58. Mallinckrodt Introduction and Business Overview
 Table 59. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 60. Mallinckrodt Inhaled Nitric Oxide Product Offerings
 Table 61. Mallinckrodt Recent Development
 Table 62. Praxair (Linde plc) Company Information
 Table 63. Praxair (Linde plc) Introduction and Business Overview
 Table 64. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 65. Praxair (Linde plc) Inhaled Nitric Oxide Product Offerings
 Table 66. Praxair (Linde plc) Recent Development
 Table 67. Air Liquide Company Information
 Table 68. Air Liquide Introduction and Business Overview
 Table 69. Air Liquide Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 70. Air Liquide Inhaled Nitric Oxide Product Offerings
 Table 71. Air Liquide Recent Development
 Table 72. BOC Healthcare (Linde Group) Company Information
 Table 73. BOC Healthcare (Linde Group) Introduction and Business Overview
 Table 74. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 75. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Offerings
 Table 76. BOC Healthcare (Linde Group) Recent Development
 Table 77. Key Raw Materials Lists
 Table 78. Raw Materials Key Suppliers Lists
 Table 79. Inhaled Nitric Oxide Downstream Customers
 Table 80. Inhaled Nitric Oxide Distributors List
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources


List of Figures
 Figure 1. Inhaled Nitric Oxide Product Picture
 Figure 2. Global Inhaled Nitric Oxide Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Inhaled Nitric Oxide Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Inhaled Nitric Oxide Sales Volume (2020-2031) & (M L)
 Figure 5. Global Inhaled Nitric Oxide Sales Price (2020-2031) & (US$/L)
 Figure 6. Inhaled Nitric Oxide Report Years Considered
 Figure 7. Global Inhaled Nitric Oxide Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Inhaled Nitric Oxide Players Sales Volume Ranking (2024) & (M L)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Inhaled Nitric Oxide Revenue in 2024
 Figure 10. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. 800 ppm Picture
 Figure 12. 100 ppm Picture
 Figure 13. Others Picture
 Figure 14. Global Inhaled Nitric Oxide Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 15. Global Inhaled Nitric Oxide Sales Value Market Share by Type, 2024 & 2031
 Figure 16. Global Inhaled Nitric Oxide Sales Volume by Type (2020 VS 2024 VS 2031) & (M L)
 Figure 17. Global Inhaled Nitric Oxide Sales Volume Market Share by Type, 2024 & 2031
 Figure 18. Global Inhaled Nitric Oxide Price by Type (2020-2031) & (US$/L)
 Figure 19. Product Picture of Near-term and Pre-term Infants PPHN
 Figure 20. Product Picture of Children and Adult ARDS
 Figure 21. Product Picture of Other Diseases
 Figure 22. Global Inhaled Nitric Oxide Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 23. Global Inhaled Nitric Oxide Sales Value Market Share by Application, 2024 & 2031
 Figure 24. Global Inhaled Nitric Oxide Sales Volume by Application (2020 VS 2024 VS 2031) & (M L)
 Figure 25. Global Inhaled Nitric Oxide Sales Volume Market Share by Application, 2024 & 2031
 Figure 26. Global Inhaled Nitric Oxide Price by Application (2020-2031) & (US$/L)
 Figure 27. North America Inhaled Nitric Oxide Sales Value (2020-2031) & (US$ Million)
 Figure 28. North America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
 Figure 29. Europe Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 30. Europe Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
 Figure 31. Asia Pacific Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Inhaled Nitric Oxide Sales Value by Region (%), 2024 VS 2031
 Figure 33. South America Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 34. South America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
 Figure 35. Middle East & Africa Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 36. Middle East & Africa Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
 Figure 37. Key Countries/Regions Inhaled Nitric Oxide Sales Value (%), (2020-2031)
 Figure 38. Key Countries/Regions Inhaled Nitric Oxide Sales Volume (%), (2020-2031)
 Figure 39. United States Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 40. United States Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
 Figure 41. United States Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
 Figure 42. Europe Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 43. Europe Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
 Figure 44. Europe Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
 Figure 45. China Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 46. China Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
 Figure 47. China Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
 Figure 48. Japan Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 49. Japan Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
 Figure 50. Japan Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
 Figure 51. South Korea Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 52. South Korea Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
 Figure 53. South Korea Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
 Figure 54. Southeast Asia Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 55. Southeast Asia Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
 Figure 56. Southeast Asia Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
 Figure 57. India Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
 Figure 58. India Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
 Figure 59. India Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
 Figure 60. Inhaled Nitric Oxide Industrial Chain
 Figure 61. Inhaled Nitric Oxide Manufacturing Cost Structure
 Figure 62. Channels of Distribution (Direct Sales, and Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture